论文部分内容阅读
目的本文选用新型阿苯达唑乳剂对36例囊型包虫病患者进行临床疗效观察。方法对36例囊型包虫病的54个包囊用阿苯达唑乳剂10 mg/kg剂量进行治疗,服药3个月为1个疗程,复查一次,各疗程之间不间断连续服药。以B超影像为主要判断指征,观察不同疗程的效果,9~12个月为总疗程。结果36例患者平均近期疗效有效率94.7%,治愈率80.6%。54个包囊有效率为92.6%,治愈率81.5%。结论阿苯达唑乳剂为治疗囊型包虫病的首选药物。
Objective To evaluate the clinical efficacy of the new albendazole emulsion in 36 patients with cystic echinococcosis. Methods 36 capsules of cystic echinococcosis were treated with albendazole 10 mg / kg in a dose of 3 capsules for one course of treatment. The drug was rechecked once and the medication was continued without interruption. To B ultrasound images as the main indications to observe the effect of different courses of treatment, 9 to 12 months for the total course of treatment. Results The average effective rate of the 36 patients was 94.7% and the cure rate was 80.6%. The effective rate of 54 cysts was 92.6% and the cure rate was 81.5%. Conclusions Albendazole emulsion is the drug of choice for the treatment of cystic echinococcosis.